Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial

标题
Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial
作者
关键词
Clinical trial, phase III, Drug combinations, Antineoplastic, Gemcitabine, Neoplasm metastasis, Pancreatic neoplasms, Sensitivity and specificity, Survival analysis
出版物
EUROPEAN JOURNAL OF CANCER
Volume 105, Issue -, Pages 71-78
出版商
Elsevier BV
发表日期
2018-11-08
DOI
10.1016/j.ejca.2018.09.010

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now